Skip to search.
 TSX Up 0.86% TSX Ventures Up 0.01%

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
3.35 Up 0.77(29.84%) 12:58PM EDT - Nasdaq Real Time Price
Prev Close:2.58
Open:2.62
Bid:3.27 x 700
Ask:3.29 x 300
1y Target Est:14.37
Beta:1.22783
Earnings Date:Aug 10 - Aug 15 (Est.)
Day's Range:2.58 - 4.29
52wk Range:1.69 - 5.84
Volume:4,199,216
Avg Vol (3m):32,487
Market Cap:23.39M
P/E (ttm):N/A
EPS (ttm):-1.61
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OPXAUp 29.84%23.39M

Key Statistics

Forward P/E (1 yr):16.45
P/S (ttm):6.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.92
Quarterly EPS Est (Jun-16) :-0.22
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases based on its proprietary T-cell technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback